| Surbhi Jain, MD | |
|
1031 Bellevue Ave Ste 400, Saint Louis, MO 63117-1858 | |
| (314) 977-7455 | |
| Not Available |
| Full Name | Surbhi Jain |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1031 Bellevue Ave Ste 400, Saint Louis, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043877301 | NPI | - | NPPES |
| Entity Name | Betty Jean Kerr Peoples Health Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194797787 PECOS PAC ID: 5991618837 Enrollment ID: O20031107000168 |
News Archive
Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.
Nymox Pharmaceutical Corporation is pleased to report on the presentation of new positive data at a high-level symposium and panel discussion held at the Annual Meeting of the American Urological Association in San Francisco. The symposium was held between 6:00 and 7:00 pm EDT on Tuesday. The well-attended symposium highlighted the ongoing clinical development program for NX-1207 for the treatment of benign prostatic hyperplasia and featured expert panel discussions on the new therapy.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery so that the patient will have better vision when not using glasses.
For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition.
› Verified 1 days ago
| Entity Name | County Of St Louis Division Of Fiscal Management |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780639088 PECOS PAC ID: 0941285720 Enrollment ID: O20040628000772 |
News Archive
Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.
Nymox Pharmaceutical Corporation is pleased to report on the presentation of new positive data at a high-level symposium and panel discussion held at the Annual Meeting of the American Urological Association in San Francisco. The symposium was held between 6:00 and 7:00 pm EDT on Tuesday. The well-attended symposium highlighted the ongoing clinical development program for NX-1207 for the treatment of benign prostatic hyperplasia and featured expert panel discussions on the new therapy.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery so that the patient will have better vision when not using glasses.
For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition.
› Verified 1 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220531002655 |
News Archive
Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.
Nymox Pharmaceutical Corporation is pleased to report on the presentation of new positive data at a high-level symposium and panel discussion held at the Annual Meeting of the American Urological Association in San Francisco. The symposium was held between 6:00 and 7:00 pm EDT on Tuesday. The well-attended symposium highlighted the ongoing clinical development program for NX-1207 for the treatment of benign prostatic hyperplasia and featured expert panel discussions on the new therapy.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery so that the patient will have better vision when not using glasses.
For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Surbhi Jain, MD 200 Hawkins Dr Dept Of, Iowa City, IA 52242-1009 Ph: (319) 356-2294 | Surbhi Jain, MD 1031 Bellevue Ave Ste 400, Saint Louis, MO 63117-1858 Ph: (314) 977-7455 |
News Archive
Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.
Nymox Pharmaceutical Corporation is pleased to report on the presentation of new positive data at a high-level symposium and panel discussion held at the Annual Meeting of the American Urological Association in San Francisco. The symposium was held between 6:00 and 7:00 pm EDT on Tuesday. The well-attended symposium highlighted the ongoing clinical development program for NX-1207 for the treatment of benign prostatic hyperplasia and featured expert panel discussions on the new therapy.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SR® Extended Release tablets.
The U.S. Food and Drug Administration today approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens' power after cataract surgery so that the patient will have better vision when not using glasses.
For the first time, UNC School of Medicine researchers have used MRIs to show that babies with the neurodevelopmental condition fragile X syndrome had less-developed white matter compared to infants that did not develop the condition.
› Verified 1 days ago
Dr. Patricia Tereese Jimenez, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4444 Forest Park Ave, Div Ob Reproductive Endocrinology, Ste 3100, Saint Louis, MO 63108 Phone: 314-286-2400 Fax: 314-286-2455 | |
Anna Rabinov, ANNA RABINOV Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-747-3000 | |
Shannon Michelle Grabosch, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1031 Bellevue Ave Ste 400, Saint Louis, MO 63117 Phone: 314-781-4772 Fax: 314-645-8771 | |
Dr. Kathryn Botney, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 621 S New Ballas Rd, Suite 4005, Saint Louis, MO 63141 Phone: 314-567-5016 Fax: 314-567-1846 | |
Dr. Ann Marie S Rockamann, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3023 N Ballas Rd Ste 600d, Saint Louis, MO 63131 Phone: 314-996-4880 | |
Dr. Haifaa T. Younis, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2315 Dougherty Ferry Rd, Suite 109b, Saint Louis, MO 63122 Phone: 314-965-5553 Fax: 314-590-5972 | |
Dr. Renee M Stein, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10777 Sunset Office Dr, Suite 200, Saint Louis, MO 63127 Phone: 314-842-4802 Fax: 314-849-8721 |